Literature DB >> 27326167

Interferon-α and pericardial injury: a case report and literature review.

Fayaz A Hakim1, Sujata Singh2, Anil Pandit1, Jorge R Alegria1, John Camoriano3, Melissa L Stanton4, Farouk Mookadam1.   

Abstract

Interferon- α (IFN-α) alone or in combination with other chemotherapeutic agents has been used in the management of many malignant and non-malignant conditions. Pericarditis with or without pericardial effusion has been reported with IFN-α therapy, and available literature is limited to case reports. Pericardial constriction after interferon use has not been described in the published literature to date. We performed a systematic review of literature to address the demographic features, clinical presentation, diagnosis, treatment and outcome of interferon-related pericardial injury.

Entities:  

Year:  2014        PMID: 27326167      PMCID: PMC4832724          DOI: 10.1136/heartasia-2013-010488

Source DB:  PubMed          Journal:  Heart Asia        ISSN: 1759-1104


  16 in total

1.  Severe pleuropericarditis and cardiomyopathy induced by high dose interferon alpha-2b.

Authors:  Ohad Benjamini; Oded Kimhi; Michael Lishner
Journal:  Isr Med Assoc J       Date:  2007-06       Impact factor: 0.892

2.  Side effects of interferon-alpha therapy.

Authors:  Stefan Sleijfer; Marjolein Bannink; Arthur R Van Gool; Wim H J Kruit; Gerrit Stoter
Journal:  Pharm World Sci       Date:  2005-12

3.  Cytokine activation in pericardial fluids in different forms of pericarditis.

Authors:  S Pankuweit; A Wädlich; E Meyer; I Portig; G Hufnagel; B Maisch
Journal:  Herz       Date:  2000-12       Impact factor: 1.443

4.  Pericarditis after therapy with interferon-alpha for chronic hepatitis C.

Authors:  A Boonen; R W Stockbrügger; S van der Linden
Journal:  Clin Rheumatol       Date:  1999       Impact factor: 2.980

5.  Side effects of high-dose interferon therapy for chronic hepatitis C.

Authors:  T Okanoue; S Sakamoto; Y Itoh; M Minami; K Yasui; M Sakamoto; K Nishioji; T Katagishi; Y Nakagawa; H Tada; Y Sawa; M Mizuno; K Kagawa; K Kashima
Journal:  J Hepatol       Date:  1996-09       Impact factor: 25.083

Review 6.  Intrapericardial triamcinolone administration for autoreactive pericarditis.

Authors:  Jorie A Glick Frasiolas; William D Cahoon
Journal:  Ann Pharmacother       Date:  2010-08-24       Impact factor: 3.154

7.  Pericarditis due to interferon-alpha therapy during treatment for chronic hepatitis C.

Authors:  B Gressens; P Gohy
Journal:  Acta Gastroenterol Belg       Date:  2004 Jul-Sep       Impact factor: 1.316

8.  Pericardial cytokines in neoplastic, autoreactive, and viral pericarditis.

Authors:  Arsen D Ristić; Sabine Pankuweit; Ružica Maksimović; Rainer Moosdorf; Bernhard Maisch
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

9.  Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - case report.

Authors:  Cristina Popescu; Victoria Arama; Smaranda Gliga
Journal:  BMC Gastroenterol       Date:  2011-03-31       Impact factor: 3.067

10.  Cytokines in pericardial effusion of patients with inflammatory pericardial disease.

Authors:  Konstantinos Karatolios; Rainer Moosdorf; Bernhard Maisch; Sabine Pankuweit
Journal:  Mediators Inflamm       Date:  2012-04-11       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.